HIV Molecular Biology and Pathogenic Mechanisms of AIDS
HIV分子生物学与艾滋病发病机制
基本信息
- 批准号:7733193
- 负责人:
- 金额:$ 44.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAdjuvantAffinityAmino Acid MotifsAnimalsBasic Cancer ResearchBindingBinding SitesBiochemical GeneticsCell NucleusCell physiologyCellsComplementary DNAComplexDNADNA VaccinesDNA deliveryDataDevelopmentDiseaseDoseDoxycyclineElementsEnsureEvolutionFamilyG Protein-Coupled Receptor GenesGene ExpressionGene TargetingGenesGenetic TranscriptionGenomeGenomicsGoalsHIVHIV-1Immune responseImmunotherapyIn VitroIndiumInterleukin-12Interleukin-15InterventionKnock-outKnockout MiceKnowledgeLengthLibrariesLigandsLinkLiteratureMacacaMalignant NeoplasmsMediatingMessenger RNAMethodologyMethodsMolecularMolecular BiologyMusMutagenesisMutateNamesNuclear ExportNuclear Receptor GenePathologic ProcessesPathway interactionsProcessProductionProteinsRNARNA BindingRNA SplicingRNA TransportRNA-Binding ProteinsReporterRetrotranspositionRetrotransposonRetroviral VectorRetroviridaeSiteStructureSubfamily lentivirinaeSystemTechnologyTetracyclineTetracyclinesTrans-ActivatorsTranscriptTranslationsVaccinationVaccinescytokinedesireembryonic stem cellexpression vectorgene functiongene therapygene transfer vectorimprovedin vivointerleukin-15 receptorknockout genemRNA Exportmacromoleculemammalian genomemouse genomenew technologynovelpractical applicationpreventrecombinasetooltraffickingvector
项目摘要
Summary We have previously identified an extensive family of RNA transport elements (RTE) in the mouse genome able to replace the HIV-1 Rev/RRE posttranscriptional regulatory system, using a mutated HIV-1 DNA proviral clone as a novel molecular trap. This is general methodology for the identification of cis-acting posttranscriptional control elements in the mammalian genome. We have analyzed in detail the structure and function of the RTE element, and we have identified the cellular factor responsible for binding to RTE and linking it to the NXF1 export pathway. This protein, the RNA binding motif protein 15 (RBM15), had no previous assigned function. RBM15 recognizes RTE directly and specifically in vitro, and stimulates export and expression of RTE-containing reporter mRNAs in vivo. Tethering of RBM15 to a reporter mRNA showed that RBM15 acts by promoting mRNA export from the nucleus. We also found that RBM15 binds to NXF1 and the two proteins cooperate in stimulating RTE-mediated mRNA export and expression. Thus, RBM15 is a novel mRNA export factor and is part of the NXF1 pathway. We propose that RTE evolved as a high-affinity RBM15 ligand to provide a splicing-independent link to NXF1, thereby ensuring efficient nuclear export and expression of retrotransposon transcripts. Consistent with these data, the group of Barbara Felber has now shown that the RTE site within full-length, active retrotransposons is essential for retrotransposition. Our results contribute significantly to the further understanding of the basic mechanisms of nucleocytoplasmic traffic of macromolecules. The understanding of the regulatory mechanisms of HIV gene expression has many important practical applications. We have applied this knowledge to the development of improved DNA vaccination approaches. We also showed that the combination of CTE and RTE elements in the same mRNA can be used to increase gene expression by more than one order of magnitude. We have used the previously developed technologies of RNA optimization to optimize expression of IL-15 cytokine, and have shown that we can produce bioactive cytokine after DNA delivery in mice and macaques. We have constructed new retroviral vectors that efficiently terminate transcription/translation when inserted in gene regions, and have constructed ordered libraries of mouse embryonic stem cells that can be used to produce mice having any desired knock out. This technology streamlines the production and study of KO mice and can assist in the rapid understanding of gene function. The method was validated by developing mouse KOs for 57 GPCR genes and several nuclear receptor genes, most of which did not exist in the literature. We have used optimized expression vectors to express IL-12 or IL-15 cytokines in animals. Efficient expression results in bioactive levels of these cytokines. We are optimizing the dose of these powerful cytokines so that they will become an important molecular adjuvant for our vaccines. We have shown that the major, if not the only one, form of bioactive IL-15 is in complex with its own IL-15 Receptor alpha. We have also shown that IL-12 is a powerful inducer of immune responses after DNA vaccination.
综上所述,我们先前使用突变的HIV-1 DNA病毒前克隆作为一种新型分子陷阱,以前已经确定了小鼠基因组中广泛的RNA转运元件(RTE)家族。这是鉴定哺乳动物基因组中的顺式作用后控制元件的一般方法。我们已经详细分析了RTE元素的结构和功能,并确定了负责与RTE结合并将其链接到NXF1导出途径的细胞因子。该蛋白是RNA结合基序蛋白15(RBM15),没有以前的分配函数。 RBM15直接识别RTE,并在体外识别RTE,并刺激体内含有RTE的记者mRNA的出口和表达。将RBM15绑定到报告基因mRNA上表明,RBM15通过促进从细胞核出口的mRNA导出来起作用。我们还发现,RBM15与NXF1结合,两种蛋白在刺激RTE介导的mRNA输出和表达方面合作。因此,RBM15是一种新型的mRNA输出因子,是NXF1途径的一部分。我们建议RTE演变为高亲和力RBM15配体,以提供与NXF1的剪接无关的链接,从而确保了逆转录跨跨座子转录本的有效核输出和表达。与这些数据一致,芭芭拉·费尔伯(Barbara Felber)组现已表明,在全长,主动返回转座子中的RTE位点对于逆转录座是必不可少的。我们的结果显着有助于进一步理解大分子核细胞质流量的基本机制。对HIV基因表达的调节机制的理解具有许多重要的实际应用。我们已经将这些知识应用于改进的DNA疫苗接种方法的发展。我们还表明,同一mRNA中的CTE和RTE元素的组合可用于将基因表达提高多个数量级。我们已经使用了先前开发的RNA优化技术来优化IL-15细胞因子的表达,并表明我们可以在小鼠和猕猴中DNA后产生生物活性细胞因子。我们已经构建了新的逆转录病毒载体,这些向量在基因区域插入时有效终止转录/翻译,并构建了小鼠胚胎干细胞的有序文库,这些库可用于产生任何所需的敲除。该技术简化了KO小鼠的生产和研究,可以帮助快速理解基因功能。该方法通过为57个GPCR基因和几个核受体基因开发小鼠KOS来验证,其中大多数在文献中不存在。我们已经使用了优化的表达矢量来表达动物中的IL-12或IL-15细胞因子。有效的表达导致这些细胞因子的生物活性水平。我们正在优化这些强大的细胞因子的剂量,以便它们成为我们疫苗的重要分子佐剂。我们已经表明,生物活性IL-15的主要形式(即使不是仅有的)形式与其自身的IL-15受体α相当复杂。我们还表明,IL-12是DNA疫苗接种后免疫反应的强大诱导剂。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
George N. Pavlakis其他文献
Complexes d'il-15 et il-15r alpha et leurs utilisations
复合物 dil-15 et il-15r alpha et leurs 用途
- DOI:
- 发表时间:
2008 - 期刊:
- 影响因子:0
- 作者:
George N. Pavlakis;J. Vournakis;Barbara K. Felber;Sergio Finkielsztein - 通讯作者:
Sergio Finkielsztein
20: Heterodimeric IL-15 regulates the balance of effector and regulatory cells, favoring anti-tumor responses
- DOI:
10.1016/j.cyto.2013.06.023 - 发表时间:
2013-09-01 - 期刊:
- 影响因子:
- 作者:
Cristina Bergamaschi;Stephanie Chen;Antonio Valentin;Viraj Kulkarni;Jenifer Bear;Margherita Rosati;Candido Alicea;Rachel Kelly Beach;Raymond Sowder;Elena Chertova;Barbara K. Felber;George N. Pavlakis - 通讯作者:
George N. Pavlakis
ID: 99: Identification, function and clinical development of the heterodimeric IL-15 cytokine (hetIL-15)
- DOI:
10.1016/j.cyto.2015.08.126 - 发表时间:
2015-11-01 - 期刊:
- 影响因子:
- 作者:
George N. Pavlakis;Cristina Bergamaschi;Sin-Man Ng;Stephanie Chen;Jenifer Bear;Candido Alicea;Bethany Nagy;Raymond Sowder;Elena Chertova;Barbara K. Felber - 通讯作者:
Barbara K. Felber
8: Heterodimeric IL-15 promotes tumor control through the regulation of the balance of effector and regulatory cells via an IL-2 deprivation mechanism
- DOI:
10.1016/j.cyto.2014.07.015 - 发表时间:
2014-11-01 - 期刊:
- 影响因子:
- 作者:
Cristina Bergamaschi;Sin-Man Ng;Stephanie Chen;Jenifer Bear;Candido Alicea;Rachel K. Beach;Raymond Sowder;Elena Chertova;Barbara K. Felber;George N. Pavlakis - 通讯作者:
George N. Pavlakis
Formes d'il-15r alpha, cellules exprimant des formes d'il-15r alpha, et utilisations thérapeutiques d'il-15r alpha et de complexes il-15/il-15r alpha
il-15r α 型、il-15r α 型原细胞、il-15r α 治疗用途和 il-15/il-15r α 复合物
- DOI:
- 发表时间:
2013 - 期刊:
- 影响因子:0
- 作者:
Barbara K. Felber;Sergio Finkielszttein;George N. Pavlakis;J. Vournakis - 通讯作者:
J. Vournakis
George N. Pavlakis的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('George N. Pavlakis', 18)}}的其他基金
IMMUNOGENICITY & EFFICACY OF DNA VACCINES AGAINST SIV INFECTION
免疫原性
- 批准号:
7959065 - 财政年份:2009
- 资助金额:
$ 44.19万 - 项目类别:
HIV Molecular Biology and DNA Vaccine Approaches Against
HIV 分子生物学和 DNA 疫苗方法
- 批准号:
6948366 - 财政年份:
- 资助金额:
$ 44.19万 - 项目类别:
Heterodimeric IL-15 in Cancer Immunotherapy
异二聚体 IL-15 在癌症免疫治疗中的应用
- 批准号:
10262144 - 财政年份:
- 资助金额:
$ 44.19万 - 项目类别:
Pathogenic mechanisms of HIV, viral reservoirs and sanct
HIV的致病机制、病毒储存库和圣地
- 批准号:
6763821 - 财政年份:
- 资助金额:
$ 44.19万 - 项目类别:
Pathogenic mechanisms of HIV, viral reservoirs and sanct
HIV的致病机制、病毒储存库和圣地
- 批准号:
7053840 - 财政年份:
- 资助金额:
$ 44.19万 - 项目类别:
HIV Molecular Biology and DNA Vaccine Approaches Against
HIV 分子生物学和 DNA 疫苗方法
- 批准号:
6758418 - 财政年份:
- 资助金额:
$ 44.19万 - 项目类别:
相似国自然基金
穿透性靶向胰腺癌内cDC1的纳米佐剂调控溶酶体逃逸促进放疗诱导ICD的机制研究
- 批准号:82303680
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
多级改造的工程化外泌体自佐剂疫苗平台实现鼻上皮细胞感染拟态和粘膜递送的研究
- 批准号:32371440
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
展示PD-L1抗体的纳米锰佐剂联合放疗以诱导原位肿瘤疫苗的产生及其机制的探究
- 批准号:32371518
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
靶向FPPS的双磷酸疫苗佐剂的开发
- 批准号:82341040
- 批准年份:2023
- 资助金额:100 万元
- 项目类别:专项基金项目
应用于冠状病毒广谱疫苗开发的新型全链式免疫增强型佐剂研究
- 批准号:82341036
- 批准年份:2023
- 资助金额:110 万元
- 项目类别:专项基金项目
相似海外基金
Investigation of Synthetic DNA-based Viral Particles for Spatially Controlled Antigen Presentation
基于 DNA 的合成病毒颗粒空间控制抗原呈递的研究
- 批准号:
10253355 - 财政年份:2021
- 资助金额:
$ 44.19万 - 项目类别:
Investigation of Synthetic DNA-based Viral Particles for Spatially Controlled Antigen Presentation
基于 DNA 的合成病毒颗粒空间控制抗原呈递的研究
- 批准号:
10662377 - 财政年份:2021
- 资助金额:
$ 44.19万 - 项目类别:
Investigation of Synthetic DNA-based Viral Particles for Spatially Controlled Antigen Presentation
基于 DNA 的合成病毒颗粒空间控制抗原呈递的研究
- 批准号:
10460559 - 财政年份:2021
- 资助金额:
$ 44.19万 - 项目类别:
Approaches to inducing broadly neutralizing antibodies with immunogens mimicking steric occlusion of the MPER as configured on the HIV-1virion surface
使用模拟 HIV-1 病毒粒子表面配置的 MPER 空间封闭的免疫原诱导广泛中和抗体的方法
- 批准号:
10452514 - 财政年份:2019
- 资助金额:
$ 44.19万 - 项目类别:
Approaches to inducing broadly neutralizing antibodies with immunogens mimicking steric occlusion of the MPER as configured on the HIV-1virion surface
使用模拟 HIV-1 病毒粒子表面配置的 MPER 空间封闭的免疫原诱导广泛中和抗体的方法
- 批准号:
10220687 - 财政年份:2019
- 资助金额:
$ 44.19万 - 项目类别: